Antibody	Immunogenicity	Species	Reference	VH	VL	T20	Z-score	IgReconstruct	AbLSTM	Germline content	Hu-mAb	MG Score	Non-human MHCII binders (loose)	Non-human MHCII binders (relaxed)	Non-human MHCII binders (medium)	Non-human MHCII binders (strict)	OASis identity (loose)	OASis identity (relaxed)	OASis identity (medium)	OASis identity (strict)
3F8	100.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLKESGPGLVAPSQSLSITCTVSGFSVTNYGVHWVRQPPGKGLEWLGVIWAGGITNYNSAFMSRLSISKDNSKSQVFLKMNSLQIDDTAMYYCASRGGHYGYALDYWGQGTSVTVSS	SIVMTQTPKFLLVSAGDRVTITCKASQSVSNDVTWYQQKAGQSPKLLIYSASNRYSGVPDRFTGSGYGTAFTFTISTVQAEDLAVYFCQQDYSSFGGGTKLEIK	74.17902	-1.3485	-3.8154303468529953	1.2729848999999998	0.6342517776341305	0.01	5079.047839738183	22	30	31	32	0.6811594202898552	0.4975845410628021	0.2898550724637681	0.2028985507246377
Abagovomab	68.1	Mouse	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221001/	QVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSS	DIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIK	67.55306999999999	-1.6235	-2.9927795736384377	1.304958	0.6693238042880704	0.025	5303.898979925327	16	21	24	24	0.6333333333333334	0.4333333333333333	0.2333333333333334	0.1904761904761905
Abciximab	35.5	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLQQSGAELVKPGASVKLSCTASGFNIKDTYVHWVKQRPEQGLEWIGRIDPANGYTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCVRPLYDYYAMDYWGQGTSVTVSS	DILMTQSPSSMSVSLGDTVSITCHASQGISSNIGWLQQKPGKSFMGLIYYGTNLVDGVPSRFSGSGSGADYSLTISSLDSEDFADYYCVQYAQLPYTFGGGTKLEIK	66.04927	-1.5379999999999998	-3.8682089285207057	1.2660764	0.6562475457472708	0.0125	5046.512770549583	13	19	24	25	0.5952380952380953	0.4285714285714287	0.2095238095238096	0.180952380952381
Abrilumab	0.4	Human	https://www.gastrojournal.org/article/S0016-5085(18)35283-1/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F	QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIK	90.070785	0.133	0.8303707589093914	0.2721308	0.9295897354664977	0.998	9019.816661061188	0	0	3	3	0.99043062200957	0.9856459330143547	0.8755980861244022	0.8564593301435408
Actoxumab	0.0	Human	"MK-3415 no ADA present
https://www.tga.gov.au/sites/default/files/auspar-bezlotoxumab-180924-cer.pdf"	QVQLVESGGGVVQPGRSLRLSCAASGFSFSNYGMHWVRQAPGKGLEWVALIWYDGSNEDYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARWGMVRGVIDVFDIWGQGTVVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPWTFGQGTKVEIK	91.92152	1.0095	0.06810200432875596	0.44425675	0.9204075379194117	1.0	9439.730055294314	0	2	4	5	0.9765258215962435	0.9248826291079806	0.8920187793427226	0.8685446009389669
Adalimumab	14.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK	90.18736999999999	0.879	0.47645625941809266	0.43690428	0.9011740171468294	0.9995	9325.819358935509	6	7	10	11	0.9481132075471708	0.8962264150943403	0.8396226415094341	0.8254716981132075
Aducanumab	5.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651340/	QVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK	93.99257	1.1480000000000001	0.7403941479971314	0.38181826	0.9221058185107024	1.0	9824.481552499632	0	1	2	2	0.9581395348837206	0.9441860465116276	0.8883720930232557	0.8790697674418604
Afutuzumab	6.6	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125486s017s018lbl.pdf	QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS	DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK	83.72772	-0.8945000000000001	-1.6395015037414886	0.78536236	0.8321953781512605	0.696	7068.220793317324	10	15	19	23	0.7674418604651161	0.7069767441860463	0.6511627906976744	0.627906976744186
Alemtuzumab	5.1	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK	78.961085	-0.3095	-1.632062346304828	0.8534309000000001	0.785278442882521	0.8385	6816.2124720306065	8	11	16	19	0.8443396226415107	0.7735849056603785	0.6367924528301891	0.5849056603773586
Alirocumab	3.9	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125559s019s020lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS	DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK	89.45036999999999	0.40549999999999997	-0.16946385999035274	0.44676167	0.896805159742013	1.0	8845.943563009485	0	3	7	9	0.9767441860465109	0.934883720930232	0.8511627906976741	0.7534883720930232
Amatuximab	29.2	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057907/	QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSS	DIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIK	64.80062	-1.9905000000000002	-3.5965128615520094	1.2953972	0.6358807674013001	0.0195	4881.909469265862	10	15	18	19	0.5215311004784688	0.3205741626794258	0.1770334928229665	0.1196172248803828
Andecaliximab	21.2	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113706/	QVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIK	91.029685	0.0165	-3.1242635082192893	0.7467815	0.7537180008126778	0.425	6744.077808262073	7	12	16	19	0.8446601941747571	0.7378640776699028	0.6213592233009708	0.5679611650485437
Anifrolumab	3.3	Human	https://ard.bmj.com/content/76/Suppl_2/870.2	EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK	91.03997	-0.10500000000000001	0.5876325565290077	0.39926654	0.9163105413105413	1.0	9094.82768529679	0	0	2	10	0.9760765550239241	0.9377990430622016	0.8899521531100483	0.7942583732057417
Arcitumomab	0.5	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVKLVESGGGLVQPGGSLRLSCATSGFTFTDYYMNWVRQPPGKALEWLGFIGNKANGYTTEYSASVKGRFTISRDKSQSILYLQMNTLRAEDSATYYCTRDRGLRFYFDYWGQGTTLTVSS	QTVLSQSPAILSASPGEKVTMTCRASSSVTYIHWYQQKPGSSPKSWIYATSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQHWSSKPPTFGGGTKLEIK	69.73222	-1.0665	-2.846324425537338	0.81382805	0.7091844690472477	0.0	5382.051286845272	8	14	23	24	0.7677725118483414	0.5924170616113744	0.3744075829383885	0.3080568720379147
Atezolizumab	28.9	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK	89.819135	1.1305	-0.7445106604045312	0.6053434	0.8493980674798036	0.958	8231.242041270372	6	10	13	16	0.8708133971291875	0.7990430622009577	0.6842105263157897	0.645933014354067
Avelumab	5.0	Human	https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0586-0/tables/2	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	90.82972	1.242	0.3842313419031177	0.5266805	0.9068181818181817	0.9975	9345.72322935094	4	9	12	14	0.9205607476635507	0.873831775700934	0.8504672897196258	0.8364485981308409
Basiliximab	1.5	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS	QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK	78.07167	-1.9535	-3.5594828671316456	1.3345908000000002	0.6655982905982907	0.0025	4787.585790494157	14	18	23	23	0.6097560975609758	0.3902439024390246	0.2536585365853659	0.1658536585365854
Bavituximab	58.0	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSS	DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELK	65.94293499999999	-1.772	-3.6028569868843805	1.3750608999999998	0.6582943925233644	0.0	4848.874339269412	9	14	19	23	0.62085308056872	0.4218009478672983	0.1990521327014217	0.1232227488151659
Begelomab	28.0	Mouse	https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-begedina_en.pdf	QVQLQQSGAELVKPGASVKLSCKASGYTFRSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCARWTVVGPGYFDVWGAGTTVTVSS	QIVLTQSPAIMSASPGEKVTITCSASSSVSYMNWFQQKPGTSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPNTFGGGTKLEIK	67.81997	-1.3170000000000002	-2.927638607069272	1.1364555	0.6682389937106918	0.0	5382.600454594933	6	12	19	20	0.7095238095238096	0.480952380952381	0.2095238095238096	0.1476190476190476
Belimumab	2.4	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761043lbl.pdf	QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSS	SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVL	87.35407000000001	-0.44499999999999995	-0.34091281362982906	0.8013435	0.8624661246612466	0.9824999999999999	7263.75091129087	5	6	8	11	0.920930232558139	0.87906976744186	0.7627906976744184	0.7395348837209301
Benralizumab	13.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf	EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK	81.68037	-0.2895	-1.023586179592812	0.8864719000000001	0.8064802656986174	0.7955	7085.852664071418	4	12	15	16	0.8018867924528317	0.7075471698113219	0.5896226415094343	0.5518867924528302
Berlimatoxumab	0.0	Human	https://www.ema.europa.eu/en/documents/assessment-report/zinplava-epar-public-assessment-report_en.pdf	ELQLQESGPGLVKPSETLSLTCTVSGGSISSGSYYWDWIRQPPGKGLEWIGNIYKSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARERGMHYMDVWGKGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQQFDPPFTFGGGTKVEIK	91.22957	0.4099999999999999	0.06280107849036748	0.41070288	0.9084661902144036	0.9215	9363.548018561247	0	1	2	2	0.9238095238095235	0.9047619047619045	0.8380952380952381	0.8285714285714286
Bevacizumab	0.3	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK	81.45546999999999	0.626	-1.356996877447239	0.8670985000000001	0.8057138515310387	0.8545	7442.7604909876245	11	14	18	18	0.8457943925233631	0.7523364485981296	0.6495327102803733	0.6214953271028034
Bezlotoxumab	0.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf	EVQLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIFYPGDSSTRYSPSFQGQVTISADKSVNTAYLQWSSLKASDTAMYYCARRRNWGNAFDIWGQGTMVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSTWTFGQGTKVEIK	94.30521999999999	0.414	0.8151738244756224	0.39196315	0.9445222533457829	1.0	10216.163134595818	0	0	3	3	0.9857819905213275	0.9573459715639815	0.8720379146919433	0.8720379146919433
Bimekizumab	12.8	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401985/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMAWVRQAPGKGLEWVATITYEGRNTYYRDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGSIYRLWFAHWGQGTLVTVSS	AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK	79.535785	0.36650000000000005	-1.7876329803567166	0.6847373000000001	0.8025420560747664	0.8775	6692.631168336208	12	14	21	22	0.7685185185185192	0.708333333333334	0.6203703703703707	0.5787037037037038
Birtamimab	0.0	Humanized/Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470113/	EVQLVESGGGLVQPGGSLRLSCAASGFTFNTYAMYWIRQAPGKGLEWVARIRSKSNNYAIYYADSVKDRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARPYSDSFAYWGQGTLVTVSS	DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSTGNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPFTFGGGTKVEIK	83.51632	-0.35950000000000004	-1.3639281860587154	0.5761295999999999	0.8405987394957983	0.6825	7455.326983389709	1	5	15	21	0.9116279069767437	0.851162790697674	0.7348837209302324	0.7023255813953487
Bleselumab	2.2	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972670/#ajt15560-sup-0005	QLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIK	94.3228	0.311	0.23104080526060944	0.53314316	0.9232808358022766	1.0	8737.724114015433	3	5	6	7	0.9526066350710907	0.9146919431279625	0.8530805687203792	0.8341232227488151
Blinatumomab	1.4	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSGAELVRPGSSVKISCKASGYAFSSYWMNWVKQRPGQGLEWIGQIWPGDGDTNYNGKFKGKATLTADESSSTAYMQLSSLASEDSAVYFCARRETTTVGRYYYAMDYWGQGTTVTVSS	DIQLTQSPASLAVSLGQRATISCKASQSVDYDGDSYLNWYQQIPGQPPKLLIYDASNLVSGIPPRFSGSGSGTDFTLNIHPVEKVDAATYHCQQSTEDPWTFGGGTKLEIK	67.48517	-1.2355	-3.9960645433948017	1.5261755	0.6855565242662016	0.056	5231.239160200975	7	14	18	19	0.6073059360730593	0.4794520547945205	0.3424657534246575	0.2602739726027397
Bococizumab	25.5	Humanized	https://www.ncbi.nlm.nih.gov/pubmed/31529318	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK	86.30853499999999	0.2535	-0.3175896739286534	0.5926956999999999	0.8625455409472518	0.8855	8085.864355479286	6	8	15	15	0.8421052631578951	0.8038277511961726	0.7464114832535886	0.736842105263158
Brazikumab	2.5	Human	https://www.gastrojournal.org/article/S0016-5085(17)35401-X/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL	92.672685	1.269	0.9585799333110447	0.21217167	0.9196091252542866	1.0	9773.16732819838	0	0	1	2	0.9863013698630134	0.963470319634703	0.91324200913242	0.9041095890410958
Brentuximab	35.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSA	DIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIK	69.34286999999999	-1.2095	-3.029639352875911	1.2707336999999999	0.7067452067452067	0.0	5408.16970078627	5	9	12	16	0.64622641509434	0.5283018867924529	0.3962264150943396	0.3349056603773585
Brodalumab	3.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK	96.029685	0.3335	0.574109350619159	0.27394158	0.9367547534643894	1.0	10181.61023835046	0	1	2	4	0.9855072463768119	0.9710144927536234	0.9371980676328503	0.9227053140096618
Burosumab	5.0	Human	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223702/
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761068s000lbl.pdf"	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIK	95.3458	0.17450000000000002	0.847293026813762	0.3618433	0.9473875181422352	0.998	9093.291972696488	0	1	4	5	0.9516908212560393	0.908212560386474	0.8405797101449278	0.7874396135265701
Canakinumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881252/#R77	QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPGKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSS	EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIK	80.67487	0.11050000000000004	-1.1777849243711997	0.3631978	0.9351338507840964	1.0	6729.828271642372	1	2	5	8	0.9808612440191393	0.9425837320574166	0.8995215311004786	0.8803827751196173
Cemiplimab	1.3	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761097s000lbl.pdf	EVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFR	84.328135	0.16899999999999998	-0.4315051436295348	0.51688236	0.843238277817717	0.997	7492.569314607404	4	4	12	17	0.9278846153846145	0.8749999999999993	0.6874999999999998	0.6298076923076923
Cendakimab	3.0	Humanized	https://www.gastrojournal.org/article/S0016-5085(18)35208-9/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F	EVTLRESGPGLVKPTQTLTLTCTLYGFSLSTSDMGVDWIRQPPGKGLEWLAHIWWDDVKRYNPALKSRLTISKDTSKNQVVLKLTSVDPVDTATYYCARTVSSGYIYYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTISCRASQDIRNYLNWYQQKPGKAPKLLIFYTSKLHSGVPSRFSGSGSGTDYTLTISSLQPEDIATYYCQQGNTLPLTFGGGTKVEIK	80.97457	-0.6515000000000001	-0.9675805109306959	0.88982785	0.7992173846972115	0.5955	7008.282588481921	10	18	21	23	0.8598130841121481	0.7570093457943913	0.6168224299065413	0.5607476635514016
Certolizumab	8.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK	83.62116999999999	0.676	-1.8079921109203894	0.74315083	0.797679391731348	0.8585	7501.767142301093	11	14	15	16	0.8516746411483259	0.746411483253589	0.6411483253588517	0.6267942583732057
Cetuximab	5.0	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA	DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK	61.67856999999999	-1.6535000000000002	-3.997097091544892	1.4282376	0.6179612031728579	0.0025	4760.048469204516	6	13	22	25	0.6619047619047618	0.4761904761904761	0.2523809523809524	0.1904761904761905
Cinpanemab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771554/	EVQLVESGGGLVEPGGSLRLSCAVSGFDFEKAWMSWVRQAPGQGLQWVARIKSTADGGTTSYAAPVEGRFIISRDDSRNMLYLQMNSLKTEDTAVYYCTSAHWGQGTLVTVSS	SYELTQPPSVSVSPGQTARITCSGEALPMQFAHWYQQRPGKAPVIVVYKDSERPSGVPERFSGSSSGTTATLTITGVQAEDEADYYCQSPDSTNTYEVFGGGTKLTVL	89.514985	-0.1255	-1.021650051324591	0.5910595999999999	0.8416502785971812	0.99	6142.0588521310165	6	9	15	15	0.8390243902439027	0.7317073170731709	0.575609756097561	0.5414634146341464
Clazakizumab	1.8	Humanized	https://onlinelibrary.wiley.com/doi/full/10.1002/art.39700	EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS	AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK	80.71977	0.634	-0.7380136536100144	0.70528865	0.8056818181818182	0.9530000000000001	6907.436009095445	5	6	12	13	0.7943925233644851	0.738317757009345	0.6588785046728969	0.6355140186915887
Clivatuzumab	10.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLQQSGAEVKKPGASVKVSCEASGYTFPSYVLHWVKQAPGQGLEWIGYINPYNDGTQYNEKFKGKATLTRDTSINTAYMELSRLRSDDTAVYYCARGFGGSYGFAYWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTMTCSASSSVSSSYLYWYQQKPGKAPKLWIYSTSNLASGVPARFSGSGSGTDFTLTISSLQPEDSASYFCHQWNRYPYTFGGGTRLEIK	77.33997	-0.6315	-1.709013811510598	0.8369525999999999	0.7712418300653594	0.6675	6427.5231860892445	9	11	12	12	0.7772511848341239	0.6824644549763041	0.5402843601895735	0.4881516587677724
Coltuximab	33.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557033/	QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS	EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK	81.146185	-1.327	-3.209881295751406	1.0836477	0.7099358974358975	0.23750000000000002	5475.142744819618	5	12	15	15	0.7163461538461534	0.5288461538461536	0.4038461538461538	0.298076923076923
Conatumumab	0.0	Human	https://link.springer.com/article/10.1007/s00280-010-1544-1	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYFWSWIRQLPGKGLEWIGHIHNSGTTYYNPSLKSRVTISVDTSKKQFSLRLSSVTAADTAVYYCARDRGGDYYYGMDVWGQGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQGISRSYLAWYQQKPGQAPSLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGSSPWTFGQGTKVEIK	90.905785	0.41150000000000003	0.45205911190747355	0.36302596	0.9143139040680024	1.0	9101.425443786666	0	0	3	5	0.9999999999999991	0.9579439252336441	0.8831775700934574	0.808411214953271
Concizumab	17.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSS	DIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIK	82.04717	-0.389	-1.793225381825903	0.6650486999999999	0.8472550177095632	0.6595000000000001	7410.897521013342	4	7	15	16	0.8847926267281104	0.8248847926267279	0.6866359447004606	0.6497695852534562
Crenezumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962917/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK	92.091685	0.0025000000000000577	-1.0837079965968475	0.41710946	0.8794642857142857	0.8454999999999999	8136.346079383998	3	4	6	9	0.9423076923076917	0.9038461538461533	0.8221153846153844	0.7740384615384615
Crizanlizumab	0.9	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761128s000lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK	82.505535	0.1545	-0.8698572958705648	0.7110776999999999	0.8180844779205434	0.8674999999999999	7430.067260545988	1	1	2	5	0.8248847926267278	0.7649769585253453	0.7188940092165897	0.6866359447004609
Dacetuzumab	0.0	Humanized	https://jhoonline.biomedcentral.com/articles/10.1186/1756-8722-7-44	EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK	85.93072	0.31450000000000006	-1.6859361127789425	0.8147970999999999	0.7745144110275689	0.7845	6755.345812954884	2	6	13	16	0.8380952380952374	0.7571428571428566	0.6619047619047617	0.6047619047619047
Daclizumab	19.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS	DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK	89.61363499999999	-0.1335	-0.9449870111765726	0.6181934	0.8245770982433311	0.7765	7348.736425357546	3	6	11	12	0.8349514563106795	0.7766990291262135	0.6941747572815533	0.6601941747572815
Dalotuzumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753462/	QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK	86.96348499999999	-0.6465	-1.5550938036469661	0.6482926	0.8603861416361416	0.87	7329.515845076869	5	9	17	18	0.9014084507042242	0.812206572769952	0.6431924882629103	0.60093896713615
Dapirolizumab	8.9	Humanized	https://journals.sagepub.com/doi/full/10.1177/0961203315574558	EVQLVESGGGLVQPGGSLRLSCAVSGFSSTNYHVHWVRQAPGKGLEWMGVIWGDGDTSYNSVLKSRFTISRDTSKNTVYLQMNSLRAEDTAVYYCARQLTHYYVLAAWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASEDLYYNLAWYQRKPGKAPKLLIYDTYRLADGVPSRFSGSGSGTDYTLTISSLQPEDFASYYCQQYYKFPFTFGQGTKVEIK	77.61652	0.2915	-1.9360758947267425	0.90221715	0.7760573419927135	0.7985	6595.309205147151	13	19	20	22	0.7655502392344505	0.6842105263157899	0.6220095693779906	0.5885167464114833
Daratumumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK	93.62582	1.1524999999999999	0.8650543606249658	0.4198099	0.9245058985751494	1.0	9859.495203346596	5	6	9	9	0.9624413145539904	0.9389671361502345	0.892018779342723	0.8873239436619719
Denosumab	1.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIK	93.01183499999999	1.2309999999999999	0.5388880716445213	0.31204173	0.9225106253794778	1.0	9938.363433285736	0	1	1	1	0.9672897196261675	0.9392523364485975	0.9018691588785044	0.8738317757009345
Depatuxizumab	5.0	Humanized/Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303422/	QVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSS	DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK	86.28687	-0.789	-1.7747272627650426	0.7365716999999999	0.7743312922977763	0.6135	6319.9660913196085	6	10	19	19	0.7342995169082134	0.6618357487922713	0.4830917874396138	0.42512077294686
Derlotuximab	33.3	Chimeric	https://pubmed.ncbi.nlm.nih.gov/16918301/	QVQLKESGPGLVAPSQSLSITCTVSGFSLTDYGVRWIRQPPGKGLEWLGVIWGGGSTYYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCAKEKRRGYYYAMDYWGQGTSVTVSS	ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQQYSGYPLTFGGGTKLEIK	67.35887	-1.129	-3.207859816299507	1.2293532	0.6805555555555556	0.0	5318.095816085996	10	21	28	30	0.7783018867924532	0.5235849056603774	0.2877358490566038	0.2311320754716981
Dinutuximab	17.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSS	EIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK	81.01437	-1.4989999999999999	-3.4746793325150813	1.311592	0.6946902654867257	0.131	5464.766774021026	10	16	22	22	0.714285714285714	0.5428571428571426	0.357142857142857	0.3142857142857142
Disitamab	58.6	Humanized	https://www.sciencedirect.com/science/article/pii/S0378427419304217?via%3Dihub	EVQLVQSGAEVKKPGATVKISCKVSGYTFTDYYIHWVQQAPGKGLEWMGRVNPDHGDSYYNQKFKDKATITADKSTDTAYMELSSLRSEDTAVYFCARNYLFDHWGQGTLVTVSS	DIQMTQSPSSVSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASIRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQFATYTFGGGTKVEIK	96.295	-0.497	-1.346867087418364	0.82585686	0.8277432712215321	0.7985	7058.4436057076355	7	9	10	15	0.7990196078431367	0.7352941176470583	0.691176470588235	0.5784313725490196
Domagrozumab	9.4	Humanized	https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.386	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK	94.744685	1.0005	-1.2521373453456213	0.38480783	0.8778198517563648	0.837	8407.945394741299	3	3	7	7	0.8888888888888894	0.8357487922705319	0.7681159420289857	0.7342995169082126
Dupilumab	4.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761055s014lbl.pdf	EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIK	90.105385	-0.125	0.2592886140481868	0.47381768	0.9012142857142857	0.9975	8778.430861093571	4	5	9	9	0.9547511312217191	0.941176470588235	0.8778280542986424	0.8552036199095022
Durvalumab	3.3	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFGELAFDYWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIK	93.81756999999999	1.2080000000000002	0.7803965748024544	0.2600917	0.9401591674318945	1.0	10335.419824713645	0	0	1	1	0.9906103286384971	0.9765258215962437	0.9530516431924879	0.92018779342723
Dusigitumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377301/	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARDPYYYYYGMDVWGQGTTVTVSS	QSVLTQPPSVSAAPGQKVTISCSGSSSNIENNHVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCETWDTSLSAGRVFGGGTKLTVL	93.594685	0.13249999999999998	0.9375272761817564	0.16524501	0.9386261261261262	1.0	9657.179421126557	0	1	1	3	0.9999999999999997	0.981395348837209	0.9162790697674418	0.8930232558139535
Eculizumab	2.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK	81.79186999999999	-0.07949999999999999	-1.539390499620658	0.6682833	0.8093304734181094	0.9339999999999999	7294.469585495056	8	11	17	18	0.7840375586854454	0.7042253521126755	0.6150234741784035	0.5868544600938966
Edrecolomab	80.0	Mouse	https://pubmed.ncbi.nlm.nih.gov/7909866/	QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARDGPWFAYWGQGTLVTVSA	NIVMTQSPKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQGYSYPYTFGGGTKLEIK	79.82211999999998	-1.3915000000000002	-3.8061639374356724	1.1925778	0.6949323235578473	0.0025	5351.668553354355	9	14	19	19	0.6570048309178746	0.526570048309179	0.3188405797101451	0.2657004830917874
Efalizumab	6.3	Humanized	https://www.fda.gov/media/75713/download	EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK	82.06967	0.847	-1.6440967394760113	0.86781263	0.8111531628948792	0.627	7851.246692166831	6	7	12	13	0.8679245283018878	0.7641509433962272	0.6509433962264154	0.6226415094339623
Eldelumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946756/	QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK	91.6431	0.8565	0.036230297632454	0.47780659999999997	0.9176901450133177	1.0	9449.911753865948	2	3	4	4	0.9585253456221194	0.9354838709677417	0.8755760368663593	0.8663594470046082
Elotuzumab	18.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK	81.53092	0.706	-1.4187482344159257	0.70609426	0.8281237728736355	0.5905	7542.839701389915	2	6	7	7	0.8476190476190472	0.7571428571428568	0.7095238095238093	0.6714285714285714
Emapalumab	3.5	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761107lbl.pdf	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSS	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVL	92.14617	0.7035	0.8934222847786095	0.22201666	0.9368270709734126	1.0	10045.746227504262	0	0	0	0	0.958715596330275	0.9357798165137613	0.908256880733945	0.8944954128440368
Emibetuzumab	0.0	Humanized	https://clincancerres.aacrjournals.org/content/23/8/1910	QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK	90.94557	-0.15300000000000002	-1.031547454971039	0.48030445	0.8517310789049919	0.9215	7859.024650610698	3	7	9	10	0.8647342995169089	0.797101449275363	0.7198067632850245	0.676328502415459
Emicizumab	3.5	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761083s002s004lbl.pdf	QVQLVQSGSELKKPGASVKVSCKASGYTFTDNNMDWVRQAPGQGLEWMGDINTRSGGSIYNEEFQDRVIMTVDKSTDTAYMELSSLRSEDTATYHCARRKSYGYYLDEWGEGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASRNIERQLAWYQQKPGQAPELLIYQASRKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYCQQYSDPPLTFGGGTKVEIK	76.48737	-0.6575	-2.455603175629684	0.95330566	0.7720882745621613	0.8685	6322.342916434779	11	14	14	15	0.7238095238095231	0.6190476190476186	0.5428571428571427	0.4857142857142857
Enfortumab	1.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761137s000lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLSLQMNSLRDEDTAVYYCARAYYYGMDVWGQGTTVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISGWLAWYQQKPGKAPKFLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGGGTKVEIK	93.16582	0.973	0.7504109766364886	0.25671032	0.9335010783608915	1.0	10388.317486244829	0	0	0	0	0.9999999999999998	0.9951923076923075	0.9903846153846152	0.9759615384615383
Enokizumab	9.0	Humanized	https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-14-93	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK	83.95786999999999	0.0195	-1.386660800911802	0.6588343000000001	0.8303968132373218	0.888	7184.525006713095	6	9	10	11	0.7699530516431918	0.718309859154929	0.657276995305164	0.6338028169014084
Erenumab	2.4	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900095/	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSS	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL	91.386385	0.837	0.36742814316537836	0.47364417	0.884965034965035	1.0	8904.17775473379	5	5	9	11	0.9419642857142851	0.9241071428571423	0.8973214285714282	0.825892857142857
Etaracizumab	0.0	Humanized	https://link.springer.com/article/10.1007%2Fs10637-007-9077-0	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK	83.55187	0.6065	-0.993553292164453	0.6120241	0.8346912692707085	0.945	7676.487980836519	9	12	17	17	0.8605769230769227	0.7788461538461534	0.6874999999999999	0.6682692307692307
Etrolizumab	5.0	Humanized	https://www.gastrojournal.org/article/S0016-5085(13)01659-4/fulltext	EVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIK	82.60072	0.802	-1.2014457058930592	0.6860098000000001	0.8226695422957104	0.7625	7470.247099637962	3	4	5	15	0.9038461538461531	0.8605769230769225	0.7692307692307689	0.6923076923076922
Evolocumab	0.3	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125522s014lbl.pdf	EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS	ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL	96.645	0.16049999999999992	0.2735494689841194	0.41153258	0.9246509772636617	0.935	9557.889605003038	0	3	5	5	0.9951923076923074	0.9374999999999998	0.875	0.875
Farletuzumab	8.7	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS	DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK	78.82436999999999	0.008500000000000008	-1.5813458629246016	0.75120693	0.7862108479755539	0.7895000000000001	6767.177779866847	4	8	10	12	0.830985915492957	0.7605633802816896	0.6197183098591547	0.5539906103286385
Ficlatuzumab	0.0	Humanized	"https://www.ncbi.nlm.nih.gov/pubmed/24901237
https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.427"	QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS	DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK	79.50502	-0.615	-1.7662687666439547	0.7738984999999999	0.7955013464280056	0.62	6449.0834706790965	1	5	10	11	0.8229665071770341	0.7320574162679432	0.6507177033492826	0.5789473684210527
Fletikumab	1.7	Human	https://link.springer.com/article/10.1007/s12325-015-0191-7	QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK	87.53811999999999	0.04149999999999998	0.6549077261093667	0.6117219	0.9001030245051144	0.9975	8313.63842491919	1	3	5	7	0.935779816513761	0.8715596330275225	0.793577981651376	0.7706422018348624
Fontolizumab	7.8	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856291/	QVQLVQSGAELKKPGSSVKVSCKASGYIFTSSWINWVKQAPGQGLEWIGRIDPSDGEVHYNQDFKDKATLTVDKSTNTAYMELSSLRSEDTAVYYCARGFLPWFADWGQGTLVTVSS	DIQMTQSPSTLSASVGDRVTITCKASENVDTYVSWYQQKPGKAPKLLIYGASNRYTGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYPFTFGQGTKVEVK	77.08787	-0.4385	-2.4363834737823917	0.9891935	0.7736640306733764	0.6685000000000001	6673.511787216839	4	5	9	9	0.7548076923076917	0.6923076923076918	0.596153846153846	0.5721153846153846
Fremanezumab	1.6	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761089s000lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK	81.978635	0.3365	-0.4238608593972905	0.7128526999999999	0.8192508043511567	0.9275	6922.490354327117	10	14	17	19	0.7746478873239429	0.7276995305164312	0.6666666666666663	0.6338028169014084
Frovocimab	6.5	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852062/	EVQLVESGGGLVKPGGSLRLSCAASGFPFSKLGMVWVRQAPGKGLEWVSTISSGGGYTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGISFQGGTYTYVMDYWGQGTLVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSKSLLHRNGITYSYWYLQKPGQSPQLLIYQLSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCYQNLELPLTFGQGTKVEIK	83.973435	-0.2479999999999999	-0.9835605277752234	0.6369194	0.8370357142857143	0.9145	7178.8311638505065	13	17	19	20	0.8009049773755652	0.7285067873303165	0.67420814479638	0.6606334841628959
Fulranumab	2.9	Human	https://journals.lww.com/clinicalpain/FullText/2017/02000/Fulranumab_in_Patients_With_Pain_Associated_With.2.aspx	EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK	88.99896999999999	0.8805	0.4773941134047394	0.47007304	0.9174834739001595	0.9924999999999999	8787.28721598592	4	4	5	13	0.9345794392523359	0.9158878504672893	0.906542056074766	0.8598130841121494
Futuximab	0.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172077/	EVQLQQPGSELVRPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSRSTNYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRNGDYYVSSGDAMDYWGQGTSVTVSS	DIQMTQTTSSLSASLGDRVTISCRTSQDIGNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDFSLTINNVEQEDVATYFCQHYNTVPPTFGGGTKLEIK	68.96617	-1.382	-3.182015805053565	1.4392858999999998	0.6856241926905251	0.0375	5237.656451813672	9	17	21	22	0.6588785046728967	0.5186915887850465	0.3457943925233645	0.294392523364486
Galcanezumab	8.7	Humanized	https://n.neurology.org/content/92/15_Supplement/P1.10-017	QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK	83.03801999999999	0.019000000000000017	-1.792429650734125	0.8840591999999998	0.8253357417733449	0.843	7221.1709197461705	7	7	8	10	0.8142857142857138	0.7285714285714282	0.6714285714285713	0.6333333333333333
Galiximab	0.0	Chimeric	https://www.annalsofoncology.org/article/S0923-7534(19)41214-3/fulltext	QVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSS	ESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVL	80.95957	-0.07050000000000001	-1.5170781541488254	0.9603101	0.8073371510379385	0.6475	6755.653098910061	8	10	16	23	0.8461538461538456	0.7963800904977371	0.678733031674208	0.5927601809954751
Gancotamab	2.9	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219487/	QVQLVESGGGLVQPGGSLRLSCAASGFTFRSYAMSWVRQAPGKGLEWVSAISGRGDNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMTSNAFAFDYWGQGTLVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGFKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL	92.83622	1.307	0.27937766629460636	0.44700134	0.9225528049057461	0.9975	9790.559408319388	2	3	3	3	0.9579439252336442	0.9532710280373826	0.9205607476635511	0.9018691588785046
Ganitumab	5.2	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029434/	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGRTDAFDIWGQGTMVTVSS	DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGQGTKVEIK	93.61086999999999	-0.502	0.6417444435628467	0.25661093	0.9477415966386554	0.999	10015.679673156761	0	0	0	1	0.9767441860465116	0.9674418604651163	0.958139534883721	0.958139534883721
Gantenerumab	0.0	Human	https://www.researchgate.net/publication/264433230_Efficacy_and_safety_studies_of_gantenerumab_in_patients_with_Alzheimer's_disease	QVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSS	DIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIK	86.27322	1.2249999999999999	-1.267143990422058	0.71142775	0.8611111111111112	0.995	8261.696533627724	7	10	12	12	0.8944954128440362	0.8486238532110087	0.8073394495412842	0.8027522935779815
Gatipotuzumab	9.5	Humanized	https://www.sciencedirect.com/science/article/pii/S0959804916321256	EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS	DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK	93.886635	-0.5065	-1.0396066496938554	0.66937566	0.8559218559218559	0.6739999999999999	6935.712294561878	12	13	17	22	0.7699530516431917	0.7417840375586848	0.685446009389671	0.6150234741784038
Gedivumab	1.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655070/	EVQLVESGGGVVQPGKSLRLSCAASGLTFSSYAVHWVRQAPGKGLEWVTLISYDGANQYYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTAVYYCAVPGPVFGIFPPWSYFDNWGQGILVTVSS	EIVLTQSPATLSVSPGERATLSCRASQVISHNLAWYQQKPGQAPRLLIYGASTRASGIPARFSGSGSGTDYTLTITSLQSEDFAVYYCQHYSNWPPRLTFGGGTKVEIK	83.920935	0.5715	-0.5824202472993071	0.7644816	0.8403669724770643	1.0	7498.881397156915	4	5	11	14	0.9036697247706413	0.8623853211009167	0.7568807339449538	0.7110091743119265
Gemtuzumab	0.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSS	DIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVK	89.146635	-0.9755	-2.270784962958605	1.0434077	0.7453401677539608	0.7735000000000001	6107.893866501603	9	10	13	15	0.6919431279620861	0.6303317535545031	0.5592417061611379	0.5308056872037916
Gevokizumab	37.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS	DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK	76.23923500000001	-0.6745000000000001	-1.8287264131490981	0.79029936	0.7737149532710279	0.462	6497.69525227085	8	12	15	18	0.819905213270143	0.7345971563981051	0.6587677725118487	0.6018957345971566
Glembatumumab	3.8	Human	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879709/
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.31892"	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	92.53352	0.30150000000000005	0.6075380302677126	0.3704349	0.9302054154995332	1.0	9001.623981023837	0	1	3	7	1.000000000000001	0.9478672985781996	0.8957345971563984	0.8720379146919431
Golimumab	4.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK	92.63897	0.9894999999999999	0.44243104178292847	0.37474304	0.9259259259259258	1.0	9531.949595711509	0	1	5	9	0.9862385321100913	0.9633027522935776	0.885321100917431	0.8348623853211009
Gosuranemab	6.2	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298197/	EVHLVESGGALVKPGGSLRLSCAASGFSFSKYGMSWVRQAPGKGLEWVATISSSGSRTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAMYYCSISWDGAMDYWGQGTTVTVSS	DVVMTQSPLSLPVTLGQPASISCKSSQSIVHSNGNTYLEWYLQKPGQSPQLLVYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGTYYCFQGSLVPWAFGGGTKVEIK	81.75907	-0.4745000000000001	-1.6766711178042073	0.7238387	0.8168879731379732	0.6605	7227.315276761283	5	8	14	17	0.8920187793427222	0.8075117370892011	0.6760563380281687	0.6150234741784036
Gremubamab	2.5	Humanized	https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(18)30576-7/fulltext	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSAITMSGITAYYTDDVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEEFLPGTHYYYGMDVWGQGTTVTVSS	AIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYSASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYCLQDYNYPWTFGQGTKVEIK	88.44229999999999	0.8394999999999999	0.007164382116613285	0.52997434	0.9166159464394401	1.0	8601.994147408699	4	7	7	7	0.8878504672897191	0.8551401869158874	0.8411214953271026	0.8317757009345793
Guselkumab	6.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761061s000lbl.pdf	EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL	90.07987	0.5599999999999999	-0.13083598432419635	0.37812015	0.8991683991683992	1.0	9052.525138156168	1	2	4	6	0.910377358490567	0.8726415094339629	0.8537735849056608	0.8066037735849058
Ibalizumab	15.0	Humanized	https://aac.asm.org/content/53/2/450	QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS	DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK	82.28832	-0.565	-1.3989544538943899	1.0678885	0.8115485948477752	0.5025	6754.5808420326575	7	9	14	16	0.8073394495412839	0.7201834862385316	0.5642201834862383	0.5229357798165136
Ibritumomab	1.9	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSA	QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGAGTKLELK	65.62782	-1.755	-3.3146551031818383	1.3543398000000002	0.662155892360037	0.0005	4800.138629707088	15	19	27	31	0.6037735849056604	0.4198113207547169	0.1981132075471698	0.1179245283018868
Icrucumab	0.0	Human	https://link.springer.com/article/10.1007/s10637-013-9998-8	QAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK	93.05232	0.9125000000000001	0.8186435450701351	0.4543897	0.9232804232804234	1.0	9206.77411712809	1	1	1	1	0.9541284403669723	0.9495412844036696	0.926605504587156	0.9220183486238532
Idarucizumab	4.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYIVDWIRQPPGKGLEWIGVIWAGGSTGYNSALRSRVSITKDTSKNQFSLKLSSVTAADTAVYYCASAAYYSYYNYDGFAYWGQGTLVTVSS	DVVMTQSPLSLPVTLGQPASISCKSSQSLLYTDGKTYLYWFLQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQSTHFPHTFGGGTKVEIK	81.94936999999999	-1.457	-1.1371677107539795	0.91709673	0.8145491803278688	0.8325	6888.429886320741	9	13	24	27	0.8211009174311923	0.7431192660550456	0.6055045871559632	0.5688073394495413
Imalumab	7.4	Human	https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14289	EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYSMNWVRQAPGKGLEWVSSIGSSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAGSQWLYGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSQRIMTYLNWYQQKPGKAPKLLIFVASHSQSGVPSRFRGSGSETDFTLTISGLQPEDSATYYCQQSFWTPLTFGGGTKVEIK	87.63647	0.6655000000000001	-0.8882025492422987	0.30840766	0.8574370346903216	1.0	8117.242971552805	9	12	15	16	0.8947368421052637	0.8277511961722492	0.7703349282296652	0.7607655502392345
Inclacumab	3.6	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461388/	EVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK	91.81836999999999	0.879	0.6320759796226793	0.45947498	0.9221058185107024	1.0	9376.043960109911	0	1	2	2	0.9720930232558136	0.9441860465116276	0.883720930232558	0.8558139534883721
Indusatumab	0.0	Human	https://clincancerres.aacrjournals.org/content/22/20/5049	QVQLQQWGAGLLKPSETLSLTCAVFGGSFSGYYWSWIRQPPGKGLEWIGEINHRGNTNDNPSLKSRVTISVDTSKNQFALKLSSVTAADTAVYYCARERGYTYGNFDHWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSVSRNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTIGSLQSEDFAVYYCQQYKTWPRTFGQGTNVEIK	91.445285	0.15149999999999997	0.7289611854327573	0.37301302	0.8991203958218801	1.0	8906.836920040034	0	0	1	1	0.971428571428571	0.9476190476190473	0.895238095238095	0.8619047619047618
Infliximab	30.5	Chimeric	http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103772s5359lbl.pdf	EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS	DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK	65.935935	-1.434	-3.1245800516838256	1.1256084	0.6776090342679127	0.04	4935.922203377623	9	17	23	26	0.7014218009478669	0.5213270142180091	0.3317535545023695	0.1943127962085308
Inotuzumab	2.0	Humanized	https://link.springer.com/article/10.1186/s41120-018-0021-5	EVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSS	DVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIK	77.77792	-0.6040000000000001	-2.971674916130861	0.82351774	0.7589654663518299	0.8035000000000001	6561.235067905445	4	12	17	20	0.8248847926267273	0.7419354838709671	0.6451612903225804	0.6036866359447004
Ipilimumab	2.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	93.75188499999999	1.2530000000000001	0.32297507114296453	0.36870143	0.934871311989956	1.0	10263.532818496209	0	0	4	5	0.9809523809523807	0.9619047619047617	0.9238095238095237	0.9047619047619048
Iscalimab	1.8	Human	https://onlinelibrary.wiley.com/doi/full/10.1111/ajt.15661	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS	DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR	90.524485	-0.24349999999999994	0.42344057068686264	0.43230912	0.9017857142857143	0.9975	8409.688823399149	1	2	4	6	0.9583333333333337	0.9305555555555559	0.8750000000000001	0.8379629629629629
Itolizumab	15.8	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407739/#__sec11title	EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK	77.67328499999999	-0.07899999999999996	-2.3882500606213792	0.61183256	0.7818660174350114	0.163	6528.786089195443	4	9	12	19	0.8333333333333326	0.6904761904761898	0.5809523809523807	0.5142857142857142
Ixekizumab	8.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS	DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK	83.21042	-0.9335	-1.1986898375798214	0.65609837	0.8366596638655462	0.8820000000000001	7242.82636637451	7	9	13	16	0.8186046511627902	0.7627906976744182	0.6744186046511627	0.6232558139534884
Labetuzumab	0.0	Humanized	https://ascopubs.org/doi/full/10.1200/JCO.2017.73.9011?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed	EVQLVESGGGVVQPGRSLRLSCSASGFDFTTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDRFTISRDNAKNTLFLQMDSLRPEDTGVYFCASLYFGFPWFAYWGQGTPVTVSS	DIQLTQSPSSLSASVGDRVTITCKASQDVGTSVAWYQQKPGKAPKLLIYWTSTRHTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYSLYRSFGQGTKVEIK	82.21472	0.119	-1.4483392741808305	0.8891803	0.7722371967654986	0.7345	6943.178417448764	8	10	15	17	0.8133971291866038	0.7224880382775127	0.6124401913875601	0.5454545454545454
Lanadelumab	7.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761090s000lbl.pdf	EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSS	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIK	92.79143499999999	1.1059999999999999	-0.21251278341793883	0.6578520999999999	0.9120785648004949	0.9975	8978.521629094515	10	12	13	15	0.891509433962265	0.8679245283018875	0.825471698113208	0.787735849056604
Lebrikizumab	30.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS	DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK	79.6076	-0.8570000000000001	-0.9321460972898103	0.7941062	0.7864941212398839	0.655	6331.331947217978	7	9	15	16	0.7840375586854453	0.7089201877934267	0.6150234741784035	0.5915492957746478
Levilimab	0.0	Humanized/Chimeric	https://adisinsight.springer.com/drugs/800049269	QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYYMSWVRQAPGKGLEWVSGIYSDGTTHYGDSVKGRFTISRDNAKNTVYLQLNSLRAEDTAMYYCAKGAGPTWWYALDAWGQGTLVTVSS	DIQLTQSPSSVSVSVGERVTIDCKSSQSVLSASNTYLNWYQQKPGQAPQLLIYYASTRESGVPDRFSGSGSGTDFTLTISSLQAEDAAVYYCQQAYRAPVTFGQGTKLEIK	81.04227	0.6515	-0.9347025033116596	0.6675885	0.7922297297297297	0.895	7114.1640589536255	2	4	10	16	0.9162790697674412	0.8325581395348832	0.6883720930232556	0.6372093023255814
Lifastuzumab	18.0	Humanized	https://clincancerres.aacrjournals.org/content/early/2019/09/20/1078-0432.CCR-18-3965.full-text.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFSFSDFAMSWVRQAPGKGLEWVATIGRVAFHTYYPDSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHRGFDVGHFDFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSETLVHSSGNTYLEWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSFNPLTFGQGTKVEIK	80.87652	0.5650000000000001	-1.7255333557450632	0.59610826	0.7970238095238096	0.835	6891.782488163186	6	7	16	17	0.8379629629629635	0.7824074074074079	0.6342592592592594	0.6296296296296298
Ligelizumab	6.3	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278557/	QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK	79.822535	-0.09000000000000001	-1.9716460210117959	1.0483618000000001	0.8026745688017628	0.8600000000000001	6777.311426114877	9	15	17	17	0.7570093457943914	0.6728971962616814	0.5981308411214952	0.5841121495327102
Lintuzumab	0.0	Humanized	https://ascopubs.org/doi/full/10.1200/JCO.2005.09.133?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK	91.894385	-0.186	-1.697870141182869	0.6638589	0.8111602982292637	0.748	6770.35531639063	7	8	8	9	0.7962085308056881	0.7345971563981051	0.6729857819905217	0.6540284360189575
Loncastuximab	0.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013258/	QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS	EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK	81.146185	-1.4015	-3.319259987306248	1.0836477	0.7051282051282051	0.21250000000000002	5433.567105165972	6	12	15	15	0.7067307692307692	0.5	0.3701923076923077	0.2932692307692307
Lorvotuzumab	0.0	Humanized	https://ashpublications.org/blood/article/120/21/728/87502/Phase-I-Study-of-Lorvotuzumab-Mertansine-LM	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSS	DVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIK	88.48786999999999	-0.1645000000000001	-0.37698698334068353	0.37210387	0.8917978208232444	0.9545	8066.954921155513	7	9	12	16	0.8785046728971955	0.8411214953271022	0.7523364485981306	0.7429906542056074
Lutikizumab	16.8	Humanized	"https://ard.bmj.com/content/annrheumdis/78/3/413.full.pdf
https://onlinelibrary.wiley.com/doi/full/10.1002/art.40840"	EVQLVESGGGVVQPGRSLRLSCSASGFIFSRYDMSWVRQAPGKGLEWVAYISHGGAGTYYPDSVKGRFTISRDNSKNTLFLQMDSLRPEDTGVYFCARGGVTKGYFDVWGQGTPVTVSS	DIQMTQSPSSLSASVGDRVTITCRASGNIHNYLTWYQQTPGKAPKLLIYNAKTLADGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQHFWSIPYTFGQGTKLQIT	80.41412	0.08849999999999997	-1.8630166365253251	0.6988928000000001	0.7972983585957747	0.761	6870.293811671828	7	11	15	19	0.8190476190476181	0.7619047619047611	0.6428571428571425	0.5714285714285713
Matuzumab	10.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK	79.44667	-0.3065	-1.0603800657717792	0.68336314	0.8123733042257915	0.7204999999999999	7150.855584399177	5	6	11	11	0.791469194312797	0.739336492890996	0.6208530805687205	0.6161137440758294
Mavrilimumab	3.1	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767745/	QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL	84.96260000000001	-0.15600000000000003	-0.3711687333662557	0.48651418	0.8529279279279279	1.0	7428.513196145302	4	5	6	9	0.8790697674418599	0.809302325581395	0.7720930232558137	0.7255813953488371
Mepolizumab	13.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125526s004lbl.pdf	QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS	DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK	79.54442	-0.9284999999999999	-1.0418484965557289	0.72476274	0.8040455120101138	0.7625	6601.263931552943	13	16	16	18	0.7962962962962971	0.745370370370371	0.6620370370370373	0.6342592592592594
Modotuximab	0.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172077/	QVQLQQPGAELVEPGGSVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEINPSSGRNNYNEKFKSKATLTVDKSSSTAYMQFSSLTSEDSAVYYCVRYYGYDEAMDYWGQGTSVTVSS	DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK	75.45697	-1.8035	-3.2489084752536064	1.3337803	0.7253151260504203	0.0	5098.553175675865	14	21	29	29	0.609302325581395	0.4837209302325579	0.3674418604651162	0.3441860465116279
Mogamulizumab	4.2	Humanized	https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0815-6	EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS	DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK	80.90212	-0.583	-1.678184080526993	0.6082715	0.8143382352941178	0.776	7006.815494602346	5	7	10	17	0.8372093023255809	0.7813953488372088	0.7209302325581393	0.6790697674418603
Motavizumab	1.5	Humanized	https://www.nature.com/articles/pr2011155	QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS	DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK	80.34448499999999	-1.0115	-1.2176652990621664	0.74138796	0.8275943396226415	0.877	6966.854361086491	6	8	14	14	0.7809523809523804	0.7142857142857139	0.5619047619047619	0.5571428571428572
Moxetumomab	59.0	Mouse	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323103/	EVQLVESGGGLVKPGGSLKLSCAASGFAFSIYDMSWVRQTPEKCLEWVAYISSGGGTTYYPDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHSGYGTHWGVLFAYWGQGTLVTVSA	DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSILHSGVPSRFSGSGSGTDYSLTISNLEQEDFATYFCQQGNTLPWTFGCGTKLEI	74.79628500000001	-0.39649999999999996	-1.9148314516325142	0.9225978000000001	0.7384951679705476	0.0085	5571.925663766535	9	14	21	25	0.8028169014084503	0.6431924882629105	0.5023474178403757	0.3990610328638498
MuromonabCD3	56.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS	QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN	66.04462	-1.883	-3.592003601674286	1.2806395000000002	0.6558585698430315	0.0025	4692.224495275552	9	11	19	19	0.5789473684210528	0.3732057416267943	0.1483253588516746	0.1196172248803828
Namilumab	0.9	Human	https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-1879-x	QVQLVQSGAEVKKPGASVKVSCKAFGYPFTDYLLHWVRQAPGQGLEWVGWLNPYSGDTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCTRTTLISVYFDYWGQGTMVTVSS	DIQMTQSPSSVSASVGDRVTIACRASQNIRNILNWYQQRPGKAPQLLIYAASNLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYSMPRTFGGGTKLEIK	86.50936999999999	-0.319	-0.3652969588999838	0.60517085	0.8631508678237649	1.0	8141.996768959186	3	7	8	12	0.9428571428571425	0.8571428571428568	0.7523809523809523	0.7047619047619047
Naptumomab	72.5	Mouse	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360042/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734423/"	EVQLQQSGPDLVKPGASVKISCKASGYSFTGYYMHWVKQSPGKGLEWIGRINPNNGVTLYNQKFKDKATLTVDKSSTTAYMELRSLTSEDSAVYYCARSTMITNYVMDYWGQGTSVTVSS	SIVMTQTPTSLLVSAGDRVTITCKASQSVSNDVAWYQQKPGQSPKLLISYTSSRYAGVPDRFSGSGYGTDFTLTISSVQAEDAAVYFCQQDYNSPPTFGGGTKLEIK	70.45817	-1.006	-2.6823627018990353	1.2830534	0.6791277258566978	0.05	5620.468797222762	12	18	22	25	0.7677725118483414	0.6255924170616115	0.4028436018957345	0.3601895734597156
Natalizumab	9.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK	89.00878499999999	-0.7115	-0.9839169770769737	0.6856108	0.7918392391471085	0.7244999999999999	6483.67083529039	7	11	13	14	0.7887323943661966	0.7042253521126755	0.5962441314553987	0.5586854460093895
Navicixizumab	29.0	Humanized/Chimeric	https://link.springer.com/article/10.1007%2Fs10637-018-0665-y	QVQLVQSGAEVKKPGASVKISCKASGYSFTAYYIHWVKQAPGQGLEWIGYISNYNRATNYNQKFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARDYDYDVGMDYWGQGTLVTVSS	DIVMTQSPDSLAVSLGERATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEVPWTFGGGTKVEIK	78.45397	-0.47050000000000003	-2.284373973109031	0.6458801	0.795253236429707	0.63	6502.503898223076	12	17	21	22	0.8224299065420544	0.728971962616821	0.598130841121495	0.5607476635514018
Necitumumab	4.1	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS	EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK	92.07487	0.5055000000000001	0.5296317498144422	0.31430563	0.9130300455704023	0.9975	9687.140013355367	0	0	2	5	0.9811320754716988	0.9622641509433968	0.9339622641509436	0.8915094339622642
Netakimab	0.0	Chimeric	https://www.researchgate.net/publication/339210970_Primary_efficacy_of_netakimab_a_novel_interleukin-17_inhibitor_in_the_treatment_of_active_ankylosing_spondylitis_in_adults	QVQLVQSGGGLVQAGGSLRLSCAASGGTFATSPMGWLRQAPGKGTEFVAAISPSGGDRIYADSVKGRFTISRDNAGYFIYLQMNSLKPEDTAVYYCAVRRRFDGTSYYTGDYDSWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYSYSPVTFGQGTKVEIK	83.039185	0.45699999999999996	-0.6974078475466214	1.1484368999999999	0.8162222222222222	0.99	7197.543803914916	8	11	14	15	0.7972350230414741	0.7142857142857139	0.6682027649769583	0.640552995391705
Nirsevimab	28.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133204/	QVQLVQSGAEVKKPGSSVMVSCQASGGLLEDYIINWVRQAPGQGPEWMGGIIPVLGTVHYGPKFQGRVTITADESTDTAYMELSSLRSEDTAMYYCATETALVVSETYLPHYFDNWGQGTLVTVSS	DIQMTQSPSSLSAAVGDRVTITCQASQDIVNYLNWYQQKPGKAPKLLIYVASNLETGVPSRFSGSGSGTDFSLTISSLQPEDVATYYCQQYDNLPLTFGGGTKVEIK	83.54571999999999	-0.42	-0.3237215144432809	0.8481136	0.8356326954457796	1.0	7129.0316064464405	8	8	9	12	0.8433179723502298	0.8248847926267275	0.7096774193548385	0.6774193548387096
Nivolumab	7.7	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK	98.73998499999999	1.032	-0.12515596975169352	0.44565064	0.9326358448432719	1.0	9088.128521557372	0	3	5	6	0.9656862745098034	0.9264705882352937	0.8725490196078429	0.8137254901960784
Obexelimab	17.5	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS	DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK	72.241085	-0.032999999999999974	-2.3884235344048546	0.6999404	0.7125147579693034	0.4025	6210.7285921826415	9	13	15	21	0.7926267281105984	0.7419354838709672	0.6543778801843316	0.5852534562211982
Obiltoxaximab	2.5	Chimeric	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125509lbl.pdf	QVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIR	77.192935	-0.5645	-2.0956227247833477	0.8055734999999999	0.7753475221864446	0.5465	6652.007037942156	14	17	19	20	0.7619047619047614	0.6571428571428567	0.5857142857142855	0.4952380952380952
Obinutuzumab	6.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS	DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK	83.72772	-0.8945000000000001	-1.6395015037414886	0.78536236	0.8321953781512605	0.696	7068.220793317324	10	15	19	23	0.7674418604651161	0.7069767441860463	0.6511627906976744	0.627906976744186
Ocaratuzumab	1.0	Humanized	https://n.neurology.org/content/86/16_Supplement/P2.087	EVQLVQSGAEVKKPGESLKISCKGSGRTFTSYNMHWVRQMPGKGLEWMGAIYPLTGDTSYNQKSKLQVTISADKSISTAYLQWSSLKASDTAMYYCARSTYVGGDWQFDVWGKGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASSSVPYIHWYQQKPGQAPRLLIYATSALASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQWLSNPPTFGQGTKLEIK	80.65262	-0.07799999999999999	-1.0189814155464347	0.9131375	0.822392016217059	0.8575	6768.657253251468	4	9	13	16	0.7298578199052141	0.668246445497631	0.6161137440758298	0.5592417061611374
Ocrelizumab	1.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIK	80.701235	0.8320000000000001	-1.4640906753900744	0.8563866	0.8233065264460253	0.821	7494.373078064451	8	10	10	15	0.797169811320756	0.7358490566037748	0.6650943396226422	0.5896226415094341
Ofatumumab	0.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK	94.915685	0.91	0.9195971452678504	0.31198192	0.957867320361575	0.9975	10241.726161416373	0	0	2	3	0.9765258215962436	0.9671361502347413	0.9342723004694833	0.924882629107981
Olaratumab	3.5	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIK	90.84212	0.13849999999999996	0.36920223741091956	0.61950636	0.8868202222385753	1.0	8578.757930473841	0	1	5	8	0.9678899082568801	0.91743119266055	0.8623853211009171	0.8119266055045872
Olokizumab	9.8	Humanized	https://www.researchgate.net/publication/260914567_Efficacy_and_safety_of_olokizumab_in_patients_with_rheumatoid_arthritis_with_an_inadequate_response_to_TNF_inhibitor_therapy_Outcomes_of_a_randomised_Phase_IIb_study	EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK	82.11182	0.349	-0.8627579014355073	0.7874174	0.8299065420560747	0.8255	7280.228290652873	6	9	11	12	0.8341232227488162	0.7488151658767781	0.6682464454976306	0.6398104265402844
Omalizumab	0.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK	80.89872	0.713	-1.194529237678113	0.88085234	0.7960687960687961	0.8595	6888.580698604452	1	3	10	14	0.8472222222222229	0.796296296296297	0.6481481481481485	0.587962962962963
Onartuzumab	11.9	Humanized	https://clincancerres.aacrjournals.org/content/20/6/1666.long	EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK	78.95761999999999	0.6779999999999999	-2.1485880526567627	0.93390346	0.7812523239384249	0.7275	7091.295164692049	7	9	13	15	0.8564814814814821	0.7916666666666673	0.6666666666666669	0.638888888888889
Ontuxizumab	4.5	Humanized/Chimeric	"https://link.springer.com/article/10.1007%2Fs10637-017-0530-4
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736902/"	QVQLQESGPGLVRPSQTLSLTCTASGYTFTDYVIHWVKQPPGRGLEWIGYINPYDDDTTYNQKFKGRVTMLVDTSSNTAYLRLSSVTAEDTAVYYCARRGNSYDGYFDYSMDYWGSGTPVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQNVGTAVAWLQQTPGKAPKLLIYSASNRYTGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQYTNYPMYTFGQGTKVQIK	72.55157	-0.471	-2.328355961416116	1.2595263	0.7219235364396654	0.6505	5813.6904094360025	8	13	18	21	0.7175925925925932	0.6250000000000006	0.5000000000000001	0.4768518518518519
Opicinumab	3.6	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202679/	EVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSS	DIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIK	91.73971999999999	1.21	0.3164952224798417	0.49714294	0.9129001883239172	1.0	9512.044791852311	1	4	6	6	0.9476190476190474	0.895238095238095	0.8619047619047618	0.8571428571428571
Oportuzumab	40.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVQSGPGLVQPGGSVRISCAASGYTFTNYGMNWVKQAPGKGLEWMGWINTYTGESTYADSFKGRFTFSLDTSASAAYLQINSLRAEDTAVYYCARFAIKGDYWGQGTLLTVSS	DIQMTQSPSSLSASVGDRVTITCRSTKSLLHSNGITYLYWYQQKPGKAPKLLIYQMSNLASGVPSRFSSSGSGTDFTLTISSLQPEDFATYYCAQNLEIPRTFGQGTKVELK	88.13192	-0.14049999999999999	-1.8807293268282268	1.0079030999999998	0.7590825123152709	0.621	6041.211418082125	12	17	24	25	0.8066037735849068	0.660377358490567	0.509433962264151	0.4528301886792453
Otlertuzumab	5.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938145/	EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK	93.599785	0.047	-1.1636748260820995	0.61871064	0.853045439896874	0.8975	7517.588705467162	7	8	12	15	0.797101449275363	0.7439613526570054	0.6570048309178745	0.6231884057971014
Ozanezumab	2.5	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026380/#pone.0097803.s001	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS	DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK	90.493785	-1.285	-1.9146326035510053	0.6174228	0.8221396965865992	0.608	6609.854091786293	5	12	15	21	0.7607655502392352	0.6794258373205748	0.6363636363636368	0.5502392344497609
Palivizumab	1.1	Humanized	"https://www.ema.europa.eu/en/documents/product-information/synagis-epar-product-information_en.pdf
https://www.drugsincontext.com/safety-pharmacokinetics-extended-use-palivizumab-saudi-arabian-infants-children/"	QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS	DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK	80.06108499999999	-1.147	-1.372462737281701	0.6435331999999999	0.8223270440251573	0.8805	6757.727335339163	5	6	11	13	0.766666666666666	0.7190476190476186	0.5809523809523809	0.5714285714285714
Pamrevlumab	0.0	Human	https://www.sciencedirect.com/science/article/pii/S2213260019302620	EGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIK	88.75678500000001	0.8734999999999999	-0.2083953774410609	0.5776477	0.923481308411215	0.9975	8691.132770530894	0	0	0	0	0.9810426540284368	0.9383886255924178	0.8862559241706164	0.8483412322274881
Panitumumab	2.8	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881252/#R77	QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK	89.79137	-0.192	0.15622618182253273	0.44985202	0.9042645095421347	1.0	9014.974237988186	2	5	6	10	0.9571428571428565	0.9238095238095233	0.8809523809523806	0.7619047619047619
PankoMab	25.0	Mouse	https://www.sciencedirect.com/science/article/pii/S1046202305000113#fig1	EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS	DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK	93.886635	-0.5065	-1.0396066496938554	0.66937566	0.8559218559218559	0.6739999999999999	6935.712294561878	12	13	17	22	0.7699530516431917	0.7417840375586848	0.685446009389671	0.6150234741784038
Parsatuzumab	4.7	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388369/	EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK	78.77077	0.58	-1.6852373273458725	0.9231739	0.7802337398373984	0.817	6479.118269663132	8	8	19	20	0.7990867579908665	0.7534246575342456	0.6210045662100454	0.5799086757990868
Pateclizumab	4.7	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243296/	EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYVIHWVRQAPGKGLEWVGYNNPYNAGTNYNEKFKGRFTISSDKSKNTAYLQMNSLRAEDTAVYYCSRPTMLPWFAYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQAVSSAVAWYQQKPGKAPKLLIYSASHRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQESYSTPWTFGQGTKVEIK	82.88521999999999	0.6815	-1.582319935434423	0.9373440999999999	0.8121336923808016	0.826	7102.597262414294	5	5	12	16	0.8086124401913884	0.7799043062200964	0.6889952153110052	0.6267942583732058
Pembrolizumab	1.7	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK	79.22807	-0.33999999999999997	-1.5160418537928473	0.88083404	0.7890765765765766	0.875	6543.46426041355	4	11	15	19	0.8325581395348831	0.720930232558139	0.5953488372093021	0.5534883720930232
Pertuzumab	2.8	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK	83.14192	0.6950000000000001	-1.7995417444196562	0.8024264	0.8029136888400219	0.8815	7316.551336402668	5	8	13	15	0.8380952380952373	0.7285714285714281	0.6476190476190474	0.6095238095238095
Pexelizumab	0.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYAQKFQGRVTMTADTSTSTAYMELSSLRSEDTAVYYCARYFFGSSPNWYFVWGQGT	DIQMTQSPSLSASVGDRVTITCGASENIYGALNWYQRKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK	80.73031999999999	-0.389	-1.62317930985864	0.69658166	0.8056603773584906	0.9055	6945.628550573118	8	12	18	20	0.7853658536585367	0.702439024390244	0.6146341463414634	0.5804878048780487
Pinatuzumab	1.4	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035878/	EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK	79.61317	0.7	-1.7395496788992726	0.91713166	0.7851190476190477	0.8005	6837.073270797147	3	4	7	11	0.8240740740740745	0.7314814814814818	0.6250000000000001	0.6018518518518519
Polatuzumab	2.6	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK	82.65077	0.6655	-1.5211814033405104	0.9017877000000001	0.8039963039963041	0.7745	7141.733671864013	7	10	12	14	0.773584905660378	0.7028301886792457	0.6650943396226418	0.6415094339622642
Ponezumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651443/	QVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSS	DVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIK	89.20337	-1.5325	-0.3086493558849449	0.69408345	0.8426724137931034	0.981	6909.667139817932	8	14	15	17	0.8160377358490576	0.7075471698113216	0.6698113207547174	0.6415094339622642
Prasinezumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324684/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK	89.33918499999999	0.608	-1.311606108593581	0.41750434	0.8293790051876717	0.76	7655.982657093074	1	5	10	11	0.9530516431924877	0.8591549295774642	0.7699530516431922	0.732394366197183
Prezalumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032945/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK	92.39501999999999	1.0365	0.4885996141500384	0.40318927	0.9187842743492701	0.999	9306.905747622823	2	2	2	5	0.9622641509433969	0.9292452830188684	0.9198113207547174	0.8867924528301888
Racotumomab	85.0	Mouse	https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.25631	QVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSS	DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK	71.87037000000001	-1.096	-2.2658149732271045	1.0890485	0.7080018537112844	0.0	5670.674073259514	3	11	16	19	0.764150943396227	0.5613207547169814	0.3915094339622641	0.2971698113207547
Ramucirumab	4.1	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS	DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK	92.03438499999999	0.6279999999999999	0.1360264969023292	0.21325321	0.8986464711569448	0.976	9059.707189634331	1	2	3	3	0.985507246376812	0.9082125603864737	0.8743961352657007	0.8647342995169084
Ranibizumab	3.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK	80.720085	0.5515	-1.5379723199535826	0.96954757	0.7969759136843705	0.8595	7235.013015416602	12	16	19	19	0.8317757009345783	0.7102803738317748	0.6214953271028033	0.6028037383177567
Ravulizumab	0.2	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761108s000lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKASGHIFSNYWIQWVRQAPGQGLEWMGEILPGSGHTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK	80.80827	-0.12199999999999997	-1.6191586332274217	0.6853210999999999	0.801133752106634	0.9339999999999999	7140.208567061355	7	10	15	16	0.7840375586854452	0.6854460093896706	0.6009389671361499	0.5774647887323943
Refanezumab	9.4	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325241/	QVQLVQSGSELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARNPINYYGINYEGYVMDYWGQGTLVTVSS	DIVMTQSPDSLAVSLGERATINCKSSHSVLYSSNQKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHQYLSSLTFGQGTKLEIK	89.424785	-0.282	0.135479912963189	0.5973516999999999	0.8893849206349207	0.94	7978.076984874361	3	7	12	20	0.8963963963963957	0.8243243243243237	0.7297297297297294	0.653153153153153
Reslizumab	5.0	Humanized	https://www.sciencedirect.com/science/article/pii/S2213219817307079	EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK	81.15742	0.388	-1.1466148546543455	0.715879	0.8182001289075089	0.7755	7435.241351299359	4	9	10	10	0.8260869565217398	0.7439613526570055	0.6714975845410631	0.5942028985507247
Risankizumab	24.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761105s000lbl.pdf	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK	77.06682	-0.5925	-2.30454315960926	0.8898577	0.772196261682243	0.723	6599.878131736878	5	11	16	18	0.7677725118483423	0.6777251184834132	0.5734597156398107	0.5450236966824645
Rituximab	11.0	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA	QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK	67.64497	-1.4965	-3.242149205411292	1.2812606000000002	0.6643146733198191	0.0	5074.563686507621	10	13	22	26	0.6113744075829382	0.4644549763033172	0.2274881516587677	0.1848341232227488
Robatumumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303167/	EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS	EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK	85.95882	0.8170000000000001	-0.7957115234792531	0.39950418	0.8608031047045779	0.9650000000000001	7806.120473135117	4	4	4	11	0.9282296650717708	0.8995215311004789	0.842105263157895	0.7799043062200958
Roledumab	0.0	Human	https://onlinelibrary.wiley.com/doi/full/10.1111/j.1423-0410.2012.01603.x	QVQLVESGGGVVQPGRSLRLSCTASGFTFKNYAMHWVRQAPAKGLEWVATISYDGRNIQYADSVKGRFTFSRDNSQDTLYLQLNSLRPEDTAVYYCARPVRSRWLQLGLEDAFHIWGQGTMVTVSS	AIRMTQSPSSFSASTGDRVTITCRASQDIRNYVAWYQQKSGKAPKFLIYAASTLQSGVPSRFSGSGSGTDFTLTINSLQSEDFATYYCQQYYNSPPTFGQGTRVEIT	83.20991999999998	0.1285	-0.665964283900391	0.7562542	0.8314048360777333	0.992	6911.496922834775	5	6	15	19	0.9262672811059902	0.8755760368663588	0.7188940092165894	0.6359447004608294
Romosozumab	18.1	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf	EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK	84.96572	0.17049999999999998	-0.8999792713318748	0.7830961999999999	0.8463642580351037	0.788	8240.148324161091	3	6	9	9	0.8738317757009332	0.8130841121495316	0.7289719626168221	0.7056074766355139
Rovalpituzumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277321/	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK	83.98647	0.014500000000000013	-1.2250861318051143	0.49485585	0.849833676540472	0.9775	8053.370419380183	0	5	8	8	0.9377990430622017	0.8421052631578955	0.7224880382775122	0.6985645933014355
Sarilumab	3.8	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761037s000lbl.pdf	EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK	96.800735	0.6105	0.617177673770951	0.33366534	0.9378424105704157	0.997	9798.719847006509	0	0	0	8	0.9855072463768121	0.9806763285024159	0.9613526570048313	0.8937198067632852
Satumomab	55.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWAKQKPEQGLEWIGYISPGNDDIKYNEKFKGKATLTADKSSSTAYMQLNSLTSEDSAVYFCKRSYYGHWGQGTTLTVSS	DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYAATNLADGVPSRFSGSGSGTQYSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTRLEIK	77.47131999999999	-1.8755000000000002	-3.114273625978443	1.3475761	0.6662567634038367	0.0	5291.995080341745	12	15	20	20	0.6243902439024394	0.4731707317073173	0.2341463414634147	0.1804878048780488
Secukinumab	1.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK	90.84361999999999	0.866	0.6681887967855236	0.49720198	0.9113079615048119	0.995	9148.484136628873	2	6	7	10	0.9680365296803647	0.9178082191780819	0.8904109589041096	0.863013698630137
Setrusumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451251/	QVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSS	DIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVL	87.13367	1.2594999999999998	-0.22155575007391604	0.48806140000000003	0.8773388773388773	0.995	8726.651381636948	3	7	13	17	0.8962264150943404	0.8443396226415101	0.7924528301886795	0.759433962264151
Sifalimumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099191/	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYSISWVRQAPGQGLEWMGWISVYNGNTNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPIAAGYWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	98.913935	0.522	0.9189686646680195	0.28838548	0.9383780332056194	1.0	10698.866900268853	0	0	0	3	0.9807692307692306	0.9759615384615383	0.971153846153846	0.9615384615384615
Siltuximab	0.2	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS	QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK	72.16287	-0.7064999999999999	-2.970883119342844	0.9207605999999999	0.7098858411289044	0.0	5562.83751969046	3	12	21	24	0.7655502392344502	0.5454545454545459	0.3588516746411485	0.3157894736842106
Sirukumab	2.9	Human	https://www.fda.gov/media/106879/download	EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK	83.31727	0.58	-0.8227684980072669	0.6437406	0.8546456318376408	0.9225000000000001	7517.252560753645	10	14	20	21	0.8086124401913883	0.7368421052631585	0.6411483253588518	0.6124401913875598
Solanezumab	3.5	Humanized	https://www.sciencedirect.com/science/article/pii/S1552526015021482?via%3Dihub	EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSS	DVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK	94.243785	-0.3015	-0.9138341997193374	0.5002151	0.8883928571428572	0.8714999999999999	7758.895001979617	4	6	8	16	0.9086538461538457	0.8413461538461534	0.7788461538461536	0.7596153846153845
Suptavumab	5.0	Human	https://academic.oup.com/ofid/article/2/suppl_1/912/2635143	EVQLVESGGDLVQPGRSLRLSCVASGFTFDDYAMHWVRQAPGKGLEWVSGVSWSGSTVGYADSVKGRFTVSRDNAQKSLYLQMNSLRAEDTALYYCVKDAYKFNYYYYGLDVWGQGTTVTVSS	EIVMTQSPATLSVSPGERATLSCRASQTILSNLAWYLQKPGQAPRLLIYGASTRATGLPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK	87.92747	0.3765	0.2957941608171237	0.5456146	0.8941189879188511	1.0	8548.188169162455	2	4	7	8	0.9252336448598123	0.8691588785046724	0.7990654205607474	0.7943925233644857
Sutimlimab	8.0	Humanized/Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175298/	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSS	QIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIK	81.08171999999999	0.747	-2.3813962369766135	0.48838428	0.8132872026123465	0.755	7414.694004800957	6	10	12	14	0.8909952606635078	0.7772511848341239	0.7061611374407586	0.6777251184834124
Suvratoxumab	3.0	Human	https://aac.asm.org/content/61/1/e01020-16	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSHDMHWVRQATGKGLEWVSGIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARDRYSPTGHYYGMDVWGQGTTVTVSS	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCKQYADYWTFGQGTKVEIK	93.897985	0.7755	0.7223508698879975	0.40151709999999996	0.9360501082585833	1.0	9210.88966830176	0	0	0	1	0.9386792452830197	0.9245283018867932	0.9009433962264157	0.8396226415094342
Tabalumab	4.4	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623366/	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK	95.31177	0.4315	1.2013519115566331	0.25039583	0.93192006686422	1.0	10312.607274097714	0	0	1	2	0.9999999999999996	0.9999999999999996	0.9859813084112146	0.9626168224299064
Tafasitamab	1.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961010/	EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS	DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK	72.241085	-0.032999999999999974	-2.3884235344048546	0.6999404	0.7125147579693034	0.4025	6210.7285921826415	9	13	15	21	0.7926267281105984	0.7419354838709672	0.6543778801843316	0.5852534562211982
Talacotuzumab	17.5	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVQSGAEVKKPGESLKISCKGSGYSFTDYYMKWARQMPGKGLEWMGDIIPSNGATFYNQKFKGQVTISADKSISTTYLQWSSLKASDTAMYYCARSHLLRASWFAYWGQGTMVTVSS	DIVMTQSPDSLAVSLGERATINCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK	83.69682	-0.419	-0.8907014881144016	0.8493881	0.8388274336283186	0.875	6802.0652538495715	14	16	17	20	0.7834101382488475	0.7281105990783406	0.6820276497695851	0.6451612903225806
Tarextumab	26.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647865/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSS	DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIK	91.41567	1.376	-0.6393518446797973	0.43763167	0.8971819645732689	0.99	9202.853746975125	2	4	6	10	0.9420289855072469	0.9082125603864738	0.8743961352657007	0.8067632850241546
Temelimab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pubmed/25427053	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYEMHWVRQAPGQGLEWIGAVAPETGGTAYNQKFKGRATITADKSTSTAYMELSSLRSEDTAVYYCTSTVVPFAYWGQGTLVTVSS	QIQLTQSPSSLSASVGDRVTITCSASSSVSYMYWYQQKPGKAPKAWIYRTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYQSLPLTFGGGTKVEIK	90.183285	-0.34149999999999997	-1.881462067843819	0.8050788000000001	0.8073357189329864	0.736	6866.152745390899	4	9	12	13	0.8009708737864076	0.7087378640776698	0.6213592233009708	0.5970873786407767
Tezepelumab	2.1	Human	https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.775	QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS	SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL	90.696285	0.614	0.5719843439674075	0.45798504	0.9107468123861566	1.0	7689.904531049591	0	0	1	8	0.9672897196261676	0.9532710280373827	0.9439252336448595	0.9205607476635512
Ticilimumab	2.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500167/	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK	94.17243500000001	1.3555	0.6631566601983868	0.23100013	0.94396261682243	0.9995	10343.366588883806	0	0	0	1	0.9814814814814817	0.9768518518518521	0.9398148148148149	0.9305555555555556
Tigatuzumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883819/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK	92.966235	1.0815000000000001	-1.1138391141460162	0.48887938	0.8483827493261455	0.8460000000000001	8303.587331469287	0	2	4	5	0.9186602870813404	0.8421052631578952	0.7751196172248805	0.7511961722488039
Tildrakizumab	6.5	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK	92.875485	-0.13099999999999998	-1.9215130061570078	0.5824028	0.8260957138253303	0.7110000000000001	7647.202476705801	7	8	12	15	0.8309178743961358	0.7391304347826092	0.671497584541063	0.6328502415458938
Tocilizumab	2.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK	84.70798500000001	0.020500000000000018	-0.5809867272520127	0.6739268	0.8384120003141444	0.7925	7806.980194158716	3	10	12	14	0.9095238095238088	0.809523809523809	0.7333333333333331	0.7047619047619046
Tomuzotuximab	12.5	Chimeric	https://esmoopen.bmj.com/content/3/2/e000303	QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVST	DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK	61.699569999999994	-1.6535000000000002	-3.997097091544892	1.4156561	0.6179612031728579	0.0025	4760.048469204516	6	13	22	25	0.6619047619047618	0.4761904761904761	0.2523809523809524	0.1904761904761905
Toripalimab	1.0	Humanized	https://ard.bmj.com/content/76/6/1078	QGQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPIHGLEWIGVIESETGGTAYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGITTVATTYYWYFDVWGQGTTVTVSS	DVVMTQSPLSLPVTLGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPLTFGQGTKLEIK	80.91163499999999	-0.96	-1.497236170728998	0.97149974	0.8135	0.771	6755.468696065142	4	6	8	12	0.8190045248868771	0.7466063348416284	0.6651583710407237	0.6199095022624433
Tosatoxumab	2.1	Human	"https://www.sec.gov/Archives/edgar/data/1614067/000104746918005409/a2236377zs-1a.htm 
AR301 - ADA in 1 patient"	EVQMVQSGAEVKKPGEPLKISCKGSGYKFGTHWIGWVRQRPGKGLEWMGIIHPADSETKYSPSFQGQVSFSADKSSNTAYLHWSTLRASDTAMYYCARRSGSSSWYALDFWGQGTMVTVSS	QSVLTQSPSASGTPGQRVTISCSGGSSNIGSNTVNWYQQFPGAAPKLLIYTNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGLYVFGTGTKVTVL	83.45857	-0.29949999999999993	-0.7391621771904269	0.7039603	0.8392524756161122	1.0	7568.344018754337	0	4	7	9	0.9444444444444448	0.8564814814814818	0.6990740740740742	0.662037037037037
Tositumomab	45.5	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSG	QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGAGTKLELK	65.58681999999999	-1.7295	-3.2917035270699584	1.3683499	0.662155892360037	0.0005	4800.138629707088	15	19	27	31	0.5990566037735849	0.4198113207547169	0.1981132075471698	0.1179245283018868
Tovetumab	2.9	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209236/	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK	89.14750000000001	0.6809999999999999	0.24922788800822962	0.2678357	0.8898148148148148	1.0	8747.197649664213	2	3	4	7	0.9528301886792465	0.9103773584905671	0.8113207547169815	0.7641509433962265
Tralokinumab	0.5	Human	https://www.sciencedirect.com/science/article/pii/S0091674918308509	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSS	SYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVL	88.26282	-0.10550000000000004	-0.21714511517678253	0.39440766	0.89275956284153	1.0	7727.764812898323	1	2	5	6	0.9439252336448584	0.89252336448598	0.7616822429906537	0.7149532710280373
Trastuzumab	8.1	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK	89.552785	0.6935	-1.1931199328971558	0.765754	0.812733644859813	0.871	7489.69105166523	6	8	12	14	0.8199052132701433	0.7535545023696693	0.6445497630331758	0.6066350710900474
Tremelimumab	0.0	Human	https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-236	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK	94.17243500000001	1.3555	0.6631566601983868	0.23100013	0.94396261682243	0.9995	10343.366588883806	0	0	0	1	0.9814814814814817	0.9768518518518521	0.9398148148148149	0.9305555555555556
Ublituximab	0.0	Chimeric	https://www.tgtherapeutics.com/EHA2013PosterP111.pdf	QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSS	QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIK	66.05001999999999	-1.8005	-3.5939497931074076	1.3100463	0.6602174608250719	0.0025	4852.100931406256	13	16	25	28	0.5913461538461539	0.4615384615384616	0.201923076923077	0.1586538461538462
Ustekinumab	4.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIK	90.21722	0.07500000000000001	0.4089887765034849	0.5076183	0.9061493756381058	1.0	8976.597681897487	1	1	5	14	0.9333333333333327	0.9142857142857137	0.8428571428571425	0.7666666666666666
Utomilumab	40.7	Human	"https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0815-6
https://clincancerres.aacrjournals.org/content/24/8/1816.long"	EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS	SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL	92.550285	0.403	0.12895821510604122	0.3790357	0.8871328224776501	0.9975	7675.489504892141	1	1	9	14	0.9134615384615375	0.8749999999999991	0.7451923076923073	0.6730769230769229
Varlilumab	0.0	Human	https://ascopubs.org/doi/full/10.1200/JCO.2016.70.1508?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIK	94.43992	1.219	0.843816935688497	0.23023666	0.9430220686405404	1.0	10154.02664407052	0	0	0	0	0.9809523809523807	0.9714285714285712	0.9428571428571427	0.9238095238095237
Vatelizumab	2.6	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS	DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK	76.16402	-0.8314999999999999	-3.071006893049642	0.8098251000000001	0.7743776755985413	0.4315	5820.22194015364	9	15	19	23	0.7799043062200965	0.6555023923444984	0.5502392344497611	0.4593301435406699
Vedolizumab	9.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS	DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK	82.326735	-0.8114999999999999	-1.2203860285115746	0.7058709	0.8208013577331759	0.8125	7235.066399923284	3	9	11	15	0.8341013824884788	0.7465437788018428	0.682027649769585	0.6451612903225805
Veltuzumab	19.5	Humanized	https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.12448	QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS	DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK	76.07391999999999	-0.6405000000000001	-1.89969899750788	0.9718100000000001	0.7722594729455794	0.557	6378.737429633704	5	9	11	16	0.7582938388625602	0.6777251184834132	0.5592417061611378	0.4976303317535544
Xentuzumab	2.3	Human	https://www.nature.com/articles/s41416-020-0774-1	QVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSS	DIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVL	84.64447	1.2115	-0.31426886476078364	0.4966859	0.8543512043512044	0.974	8204.123292424669	4	4	7	15	0.8815165876777261	0.872037914691944	0.8104265402843606	0.7582938388625594
Zalutumumab	0.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK	90.167585	1.063	0.9071235166819958	0.39987990000000007	0.9126355140186916	0.9995	8802.118459671718	2	5	8	9	0.9768518518518524	0.930555555555556	0.8842592592592595	0.8472222222222223
Zolbetuximab	0.0	Chimeric	https://www.ejcancer.com/article/S0959-8049(18)30847-5/fulltext#sec2.3.3	QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS	DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK	73.461235	-1.1445	-2.0937152656221274	1.3138504	0.7289260536973152	0.0	5464.539812806395	6	10	14	16	0.706976744186046	0.562790697674418	0.4046511627906975	0.3581395348837209
Zolimomab	85.7	Mouse	https://watermark.silverchair.com/1173.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA2MwggNfBgkqhkiG9w0BBwagggNQMIIDTAIBADCCA0UGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMhC4iloU0r_SBrdCxAgEQgIIDFnEfbX3WkQ3lAKMJ7kvs2VyxfqP1zBk80FtyvtIqhW-OQWffRHjei3sk4bBReRE5QEVAbi5BCqsPo-hM1nYPV-Ft0FdBy0fMDVdeE4HclMpusuF1qKi8PB3YCuUTNfe0ZExv_542L9japH2LGRzKLd94N2QOCwbUqvvhGnHA6C_m8HpBrvZDLoAQeQX815zgRB62AWUs9QK7JRzV2_M5n6K6DSnXSyqKNi-lnCPyzYcw5oEYwKEDiPJXQXvBcRtoPVCSV-X8jz4ZX1ofYYvU_U9sELHRHlNNKhgP83nsNg36eJqJCpzm73Gv_E_Qtdc4_2Is29Uug0QkKafkGbus1qhz1jNcaFyKksw7_YLNIVko_E1GqGyHKiu5XcYz0eKiWdyGsumJZs-eIWBLe4wycxnsjNmaBgv08sYT90Z6dFxERrvHzlNF_DcdofHVR_2iOzzrAuqkURvdA7zegW5zKs3i0pb4tbPjVVNg2V6HYYI7Gj7YkXxs_rHErjyRcvCZamu2qXB95KDdRLaFaNnZ-dAKT6ECn6a_QZtuMVpyXlnuSiPA3WL0FmE90lljhywvK5EfT8H2Sms--9jqQQ98068rUqfVSj9adYG4DNFInH1GZuZXGpklKU8B6-lhA92_I8ljfJDYZZ_4ZpF-pyWrHPjBV7jcFcFsZ-RlrMqeSPskgTOzVo3_Tzqs46y4RZ_dAJniDq-g7u4O2dq19OldNZi_gQhCKzYd4bn0UVVAK2A4yCQod4Wev-sHq8m37JVRKOYTJ5swSL8IIPisyrk4dG69flbvpPugsxvoh_uVX4kXZT6X657hI2GVmO3bkx2EJ0TCaQMODbHa2HyTyHZbzKKNjqSmm3d3JhilN2AiWwofgNz2W8hCDvfLJtVDSLJ8U8G-aIx_BsGMg643Mg-lY20r9mQbXj7ZamCKxXJMRTEpUDTPl2PhO0qoi5Rm2HtHmrHZiel3bF5AOGanjhaTcpsVlWvlfGwEZj6YVMX8maQN45SW3y9SsP5ijYAc_UxXbvlzKPsNTvt2xoHwyH7xkob0jKHCFvM	QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS	QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN	66.04462	-1.883	-3.592003601674286	1.2806395000000002	0.6558585698430315	0.0025	4692.224495275552	9	11	19	19	0.5789473684210528	0.3732057416267943	0.1483253588516746	0.1196172248803828
moAb_81C6	100.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVVHWVKQNPGQGLEWIGYINPFNDGTKYNENFKGKATLTSDRSSSTAYMELSSLTSEESAVYFCARDMGREGFAYWGQGTLVTVSA	DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPRTFGGGTKLEI	75.89372	-1.948	-2.487011836682252	1.295034	0.7311421591082607	0.0	5198.380888900178	15	19	24	24	0.6291079812206577	0.5164319248826293	0.3615023474178404	0.3615023474178404
